Townsend R, Glassburn J R, Brady L W, Rowland J
Cancer Clin Trials. 1979 Winter;2(4):351-8.
A selected group of 39 patients with ovarian carcinoma were treated by whole abdominal radiation therapy with a pelvic boost. No statement as to the efficacy of this treatment program can be made for patients with Stage I, II, and IV disease because of the small number of patients with those stages who were treated by this method. A surprising 30% 5-year survival was obtained, however, in patients with Stage III disease. The challenge of ovarian carcinoma lies in the advanced stage of disease in most patients at the time of diagnosis.
一组经挑选的39例卵巢癌患者接受了全腹放疗加盆腔强化放疗。由于采用这种方法治疗的I期、II期和IV期患者数量较少，因此无法对该治疗方案对这些期别患者的疗效作出评价。然而，III期患者的5年生存率令人惊讶地达到了30%。卵巢癌的挑战在于大多数患者在诊断时疾病已处于晚期。
